Kynam Capital Management, LP
Filing Date
Global Rank
#1,351
/ 8,624
▲ 55
· as of Mar 2026
Top Industry
Biotechnology
95.0%
3Y Alpha vs SPY
+23.4%
Period ended 4 months ago
Filed May 15, 2026 · 3mo
18 quarters · since Dec 2021
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Cloned portfolio
+187.9%
SPY
+67.7%
Annualised alpha
+23.4%
Max drawdown
−42.3%
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 95% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
37 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.6%
−2.6 pts
Top 5
51.5%
−4.1 pts
Top 10
71.9%
−2.6 pts
HHI
669
Diversified−88
Portfolio Trend
18 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $1,621,136,956 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
12 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | +6,047,016 | 15,013,093 | $70,561,537 | |
| GERN | Geron Corp | +3,380,000 | 6,836,318 | $10,186,113 | |
| TVTX | Travere Therapeutics, Inc. | +1,906,034 | 2,423,918 | $72,014,603 | |
| VRDN | Viridian Therapeutics, Inc.\DE | +871,111 | 2,341,652 | $45,802,713 | |
| PRLD | Prelude Therapeutics Inc | +803,684 | 1,592,551 | $5,446,524 | |
| EVMN | Evommune, Inc. | +440,014 | 625,496 | $14,380,153 | |
| STRO | Sutro Biopharma, Inc. | +392,968 | 872,558 | $21,735,419 | |
| BEAM | Beam Therapeutics Inc. | +304,971 | 3,682,185 | $87,746,468 | |
| BNR | Burning Rock Biotech Ltd | +232,672 | 1,227,555 | $19,800,462 | |
| AMRN | Amarin Corp Plc\Uk | +83,109 | 472,382 | $6,830,643 | |
| IMCR | Immunocore Holdings plc | +28,475 | 884,937 | $26,680,850 | |
| KALV | KalVista Pharmaceuticals, Inc. | +10,000 | 1,820,954 | $36,655,804 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
9 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BCRX | Biocryst Pharmaceuticals Inc | −3,685,731 | 5,680,795 | $54,081,168 | |
| COGT | Cogent Biosciences, Inc. | −2,127,892 | 4,037,331 | $155,396,870 | |
| WVE | Wave Life Sciences Ltd. | −1,203,912 | 965,193 | $6,997,649 | |
| NRIX | Nurix Therapeutics, Inc. | −775,600 | 1,194,757 | $18,518,733 | |
| ENGN | enGene Therapeutics Inc. | −136,055 | 1,356,843 | $9,240,100 | |
| CLDX | Celldex Therapeutics, Inc. | −102,613 | 5,840,567 | $185,262,785 | |
| APLS | Apellis Pharmaceuticals, Inc. | −83,607 | 825,000 | $33,189,750 | |
| VERA | Vera Therapeutics, Inc. | −34,827 | 3,398,224 | $136,710,551 | |
| CLYM | Climb Bio, Inc. | −25,000 | 1,003,341 | $6,872,885 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | 2,247,393 | $40,408,126 | |
| LEGN | Legend Biotech Corp | 1,576,295 | $28,515,176 | |
| RVMD | Revolution Medicines, Inc. | 207,500 | $20,179,375 | |
| SLNO | Soleno Therapeutics Inc | 560,000 | $18,748,800 | |
| CADL | Candel Therapeutics, Inc. | 200,000 | $980,000 | |
| No positions match the current search. | ||||
37 tracked positions ·
$1,621,136,956 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Held | 8,050,959 | $188,070,402 | 11.60% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
Reduced | 5,840,567 | $185,262,785 | 11.43% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Held | 2,922,335 | $169,816,886 | 10.48% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 4,037,331 | $155,396,870 | 9.59% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Reduced | 3,398,224 | $136,710,551 | 8.43% | |
| BEAM |
Beam Therapeutics Inc.
Healthcare
|
Added | 3,682,185 | $87,746,468 | 5.41% | |
| TVTX |
Travere Therapeutics, Inc.
PUT
CALL
+ SHARES
Healthcare
|
Added | 2,423,918 | $72,014,603 | 4.44% | |
| CTMX |
CytomX Therapeutics, Inc.
Healthcare
|
Added | 15,013,093 | $70,561,537 | 4.35% | |
| BCRX |
Biocryst Pharmaceuticals Inc
Healthcare
|
Reduced | 5,680,795 | $54,081,168 | 3.34% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 2,341,652 | $45,802,713 | 2.83% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 3,114,132 | $44,251,815 | 2.73% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
NEW | 2,247,393 | $40,408,126 | 2.49% | |
| KALV |
KalVista Pharmaceuticals, Inc.
Healthcare
|
Added | 1,820,954 | $36,655,804 | 2.26% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Reduced | 825,000 | $33,189,750 | 2.05% | |
| LEGN |
Legend Biotech Corp
Healthcare
|
NEW | 1,576,295 | $28,515,176 | 1.76% | |
| MBX |
MBX Biosciences, Inc.
Healthcare
|
Held | 934,799 | $27,903,750 | 1.72% | |
| IMCR |
Immunocore Holdings plc
Healthcare
|
Added | 884,937 | $26,680,850 | 1.65% | |
| STRO |
Sutro Biopharma, Inc.
Healthcare
|
Added | 872,558 | $21,735,419 | 1.34% | |
| RVMD |
Revolution Medicines, Inc.
PUT
Healthcare
|
NEW | 207,500 | $20,179,375 | 1.24% | |
| BNR |
Burning Rock Biotech Ltd
Healthcare
|
Added | 1,227,555 | $19,800,462 | 1.22% | |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
NEW | 560,000 | $18,748,800 | 1.16% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 1,194,757 | $18,518,733 | 1.14% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 640,395 | $18,091,158 | 1.12% | |
| EVMN |
Evommune, Inc.
Healthcare
|
Added | 625,496 | $14,380,153 | 0.89% | |
| RLAY |
Relay Therapeutics, Inc.
Healthcare
|
Held | 1,424,259 | $14,171,377 | 0.87% | |
| GERN |
Geron Corp
Healthcare
|
Added | 6,836,318 | $10,186,113 | 0.63% | |
| ENGN |
enGene Therapeutics Inc.
Healthcare
|
Reduced | 1,356,843 | $9,240,100 | 0.57% | |
| DSGN |
Design Therapeutics, Inc.
Healthcare
|
Held | 784,606 | $8,348,207 | 0.51% | |
| WVE |
Wave Life Sciences Ltd.
Healthcare
|
Reduced | 965,193 | $6,997,649 | 0.43% | |
| CLYM |
Climb Bio, Inc.
Healthcare
|
Reduced | 1,003,341 | $6,872,885 | 0.42% | |
| AMRN |
Amarin Corp Plc\Uk
Healthcare
|
Added | 472,382 | $6,830,643 | 0.42% | |
| BHVN |
Biohaven Ltd.
Healthcare
|
Held | 702,884 | $5,946,398 | 0.37% | |
| PRLD |
Prelude Therapeutics Inc
Healthcare
|
Added | 1,592,551 | $5,446,524 | 0.34% | |
| CRBU |
Caribou Biosciences, Inc.
Healthcare
|
Held | 2,503,302 | $4,756,273 | 0.29% | |
| ALEC |
Alector, Inc.
Healthcare
|
Held | 2,000,000 | $4,300,000 | 0.27% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 1,566,317 | $2,537,433 | 0.16% | |
| CADL |
Candel Therapeutics, Inc.
Healthcare
|
NEW | 200,000 | $980,000 | 0.06% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.